Sagimet Biosciences Inc. (SGMT)
undefined
undefined%
At close: undefined
5.07
15.62%
Pre-market Dec 16, 2024, 04:29 AM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue 2.00M - - - -
Cost of Revenue - 130.00K 134.00K 124.00K 88.00K
Gross Profit 2.00M -130.00K -134.00K -124.00K -88.00K
Operating Income -30.74M -31.05M -23.72M -11.40M -14.25M
Interest Income 2.86M 553.00K 26.00K 30.00K 128.00K
Pretax Income -27.88M -30.50M -24.44M -11.37M -14.26M
Net Income -27.88M -30.50M -24.44M -11.37M -14.26M
Selling & General & Admin 12.96M 6.14M 4.38M 3.22M 5.86M
Research & Development 19.78M 24.92M 19.34M 8.18M 8.39M
Other Expenses - 3.00K -749.00K - -73.00K
Operating Expenses 32.74M 31.05M 23.72M 11.40M 14.25M
Interest Expense - - - - 64.00K
Selling & Marketing Expenses - - - - -
Cost & Expenses 32.74M 31.05M 23.72M 11.40M 14.25M
Income Tax - -31.61M -23.75M -176.30K -9.00K
Shares Outstanding (Basic) 10.46M 22.17M 22.17M 22.17M 22.17M
Shares Outstanding (Diluted) 10.46M 22.17M 22.17M 22.17M 22.17M
EPS (Basic) -2.66 -1.38 -1.1 -0.51 -0.64
EPS (Diluted) -2.66 -1.38 -1.1 -0.51 -0.64
EBITDA -30.74M -30.37M -24.31M -11.25M -14.11M
Depreciation & Amortization - 130.00K 134.00K 124.00K 88.00K